XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Finite Lived Intangible Assets [Line Items]        
Amortization expense $ 400 $ 400 $ 1,276 $ 1,300
Amortization of license agreements remainder of fiscal year 2022 400   400  
Amortization of license agreements in 2023 1,700   1,700  
Amortization of license agreements in 2024 1,700   1,700  
Amortization of license agreements in 2025 1,700   1,700  
Amortization of license agreements in 2026 1,700   1,700  
Amortization of license agreements, thereafter 5,200   $ 5,200  
Novartis | Licensing Agreement        
Finite Lived Intangible Assets [Line Items]        
Amortization period of intangible assets     21 years  
Finite-lived intangible assets, accumulated amortization 1,100   $ 1,100  
Novartis | Patents        
Finite Lived Intangible Assets [Line Items]        
Amortization period of intangible assets     14 years  
Finite-lived intangible assets, accumulated amortization $ 11,400   $ 11,400